[CH3:1][O:2][C@@H:3]([C@@H:26]1[CH2:30][CH2:29][CH2:28][N:27]1C(OC(C)(C)C)=O)[C@@H:4]([CH3:25])[C:5]([NH:7][C@@:8]1([C:17]([N:19]2[CH2:24][CH2:23][CH2:22][CH2:21][O:20]2)=[O:18])[CH2:10][C@@H:9]1[C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=1)=[O:6].[F:38][C:39]([F:44])([F:43])[C:40]([OH:42])=[O:41]>ClCCl>[F:38][C:39]([F:44])([F:43])[C:40]([OH:42])=[O:41].[CH3:1][O:2][C@@H:3]([C@@H:26]1[CH2:30][CH2:29][CH2:28][NH:27]1)[C@@H:4]([CH3:25])[C:5]([NH:7][C@@:8]1([C:17]([N:19]2[CH2:24][CH2:23][CH2:22][CH2:21][O:20]2)=[O:18])[CH2:10][C@@H:9]1[C:11]1[CH:16]=[CH:15][CH:14]=[CH:13][CH:12]=1)=[O:6]617 mg (1.2 mmol) of tert-butyl (2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-{[(1S,2R)-1-(1,2-oxazinan-2-ylcarbonyl)-2-phenylcyclopropyl]amino}-3-oxopropyl]pyrrolidine-1-carboxylate (Intermediate 24) were taken up in 44 ml of dichloromethane, 4.4 ml of trifluoroacetic acid were added and the mixture was stirred at RT for 30 min. Subsequently, the reaction mixture was concentrated under reduced pressure and the remaining residue was lyophilized from dioxane/water. 702 mg (quant.) of the deprotected compound (2R,3R)-3-methoxy-2-methyl-N-[(1S,2R)-1-(1,2-oxazinan-2-ylcarbonyl)-2-phenylcyclopropyl]-3-[(2S)-pyrrolidin-2-yl]propanamide trifluoroacetate were obtained as a crude product, which was used in the following stage without further purification.
Wird geladen…